1-2 of 2
Keywords: Electromotive drug administration
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Electromotive Drug Administration of Mitomycin C (EMDA/MMC) versus Intravesical Immunotherapy with Bacillus Calmette-Guérin (BCG) in Intermediate and High Risk Non Muscle Invasive Bladder Cancer

Available to Purchase
Subject Area:
Karger e-Journal Backfile Collection 2023 , Further Areas
Michele Zazzara, Arjan Nazaraj, Marcello Scarcia, Giuseppe Cardo, Roberto Carando, Giuseppe Mario Ludovico
Journal: Urologia Internationalis
Urol Int (2023) 107 (1): 64–71.
https://doi.org/10.1159/000520630
Published Online: 24 January 2023
... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2021 Bladder cancer Electromotive drug administration Bacillus Calmette-Guérin Intravesical treatment Non-muscle-invasive bladder cancer...
View article titled, Electromotive Drug Administration of Mitomycin C (EMDA/MMC) versus Intravesical Immunotherapy with Bacillus Calmette-Guérin (BCG) in Intermediate and High Risk Non Muscle Invasive Bladder Cancer
Open the PDF for Electromotive Drug Administration of Mitomycin C (EMDA/MMC) versus Intravesical Immunotherapy with Bacillus Calmette-Guérin (BCG) in Intermediate and High Risk Non Muscle Invasive Bladder Cancer in another window
Journal Articles

Intravesical Treatment with Electro-Mediated Administration of Mytomicin C as Prophylaxis for Intermediate and High-Risk Nonmuscle-Invasive Bladder Cancer: A Retrospective Multicenter Study

Free
Subject Area:
Further Areas
Roberto Carando, Michele Zazzara, Simone Cotrufo, Giuseppe M. Ludovico
Journal: Urologia Internationalis
Urol Int (2019) 103 (3): 285–290.
https://doi.org/10.1159/000502663
Published Online: 28 August 2019
... a better concentration of the drugs in the bladder. Aim: This study aimed to investigate the effectiveness of electromotive drug administration (EMDA) of mitomycin C (EMDA/MMC) in intermediate- and high-risk NMIBC patients 6 months after the end of induction treatment. Materials and Methods: Sixty-five...
View article titled, Intravesical Treatment with Electro-Mediated Administration of Mytomicin C as Prophylaxis for Intermediate and High-Risk Nonmuscle-Invasive Bladder Cancer: A Retrospective Multicenter Study
Open the PDF for Intravesical Treatment with Electro-Mediated Administration of Mytomicin C as Prophylaxis for Intermediate and High-Risk Nonmuscle-Invasive Bladder Cancer: A Retrospective Multicenter Study in another window